Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06628934 · ClinicalTrials.gov registry record
Wearable Gait Sensors
A clinical trial of Spinocerebellar Ataxia, sponsored by University of Chicago.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT06628934: Active study of Spinocerebellar Ataxia, sponsored by University of Chicago.
NCT06628934 is a study of Spinocerebellar Ataxia that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 600 participants, above the 16-participant average among 3 other Spinocerebellar Ataxia trials with a reported enrollment target (3650% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06628934, a study of Spinocerebellar Ataxia, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is testing body-worn sensors to measure movement during simple tests of coordination, in order to evaluate the progression and severity of Spinocerebellar ataxia.
Primary Outcome
Digital measurements collected by wearable inertial sensors during instrumented Scale for the Assessment and Rating of Ataxia (iSARA).
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-06-23 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT06628934 still lists
NCT06628934 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 16-participant average among 3 other Spinocerebellar Ataxia trials with a reported enrollment target (3650% higher).
The record links to 1 condition, with Spinocerebellar Ataxia appearing as the primary indexed condition, and to 0 interventions.
NCT06628934 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06628934 about?
NCT06628934 is a clinical study titled "Wearable Gait Sensors". This research study is testing body-worn sensors to measure movement during simple tests of coordination, in order to evaluate the progression and severity of Spinocerebellar ataxia.
What is the current status of trial NCT06628934?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2017-06-23. Estimated completion is 2026-12-31.
What conditions does trial NCT06628934 study?
This clinical trial studies the following conditions: Spinocerebellar Ataxia.
Who is sponsoring clinical trial NCT06628934?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06628934 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinocerebellar Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI